In this study, we aimed to assess the sex-specific relationship between low muscle mass and glucose fluctuations in hospitalized patients with T2DM undergoing continuous subcutaneous insulin infusion (CSII) treatments. This evidence concerns the gene INS and type 2 diabetes mellitus.